Estrella Immunopharma (ESLA) Stock Chart & Stock Price History $0.92 +0.07 (+8.23%) (As of 11/20/2024 ET) Add Compare Share Share Chart Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends Estrella Immunopharma Stock Price Performance 5 Day Performance+3.43%1 Month Performance+10.64%3 Month Performance-34.72%6 Month Performance-7.02%Year-To-Date Performance-17.07%1 Year Performance-34.25% Receive ESLA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Estrella Immunopharma and its competitors with MarketBeat's FREE daily newsletter. Email Address When it comes to NVDA… “acceleration cycles” are the key (Ad)Expert options trader Graham Lindman has been working on a new way to tap into Nvidia’s options… By simply isolating outsized “acceleration cycles” within Nvidia stock (most investors don’t even know it exists)... And thanks to many months and late nights working out the kinks of the systems… They have finally found a way to target these cycles on Nvidia over and over again.Use this link to see Nvidia Unchained right away! ESLA Stock Chart for Thursday, November, 21, 2024 ESLA Chart by TradingView Estrella Immunopharma Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization11/20/2024$0.85$0.92+8.17%$0.99$0.8531,278 shs$33.30 million11/19/2024$0.85$0.85+0.59%$0.88$0.854,101 shs$30.79 million11/18/2024$0.89$0.85-4.94%$0.90$0.815,375 shs$30.61 million11/15/2024$0.84$0.89+5.95%$0.89$0.7515,269 shs$32.21 million11/14/2024$0.84$0.84$0.84$0.753,930 shs$30.40 million11/13/2024$0.80$0.84+5.40%$0.84$0.755,995 shs$30.40 million Get the Latest News and Ratings for ESLA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Estrella Immunopharma and its competitors with MarketBeat's FREE daily newsletter. 11/12/2024$0.76$0.80+4.66%$0.81$0.7410,010 shs$28.84 million11/11/2024$0.74$0.76+2.91%$0.80$0.7419,938 shs$27.56 million11/08/2024$0.80$0.74-7.62%$0.80$0.7034,627 shs$26.78 million11/07/2024$0.79$0.80+1.37%$0.83$0.7911,859 shs$28.99 million11/06/2024$0.85$0.79-7.04%$0.92$0.7020,336 shs$28.60 million11/05/2024$0.78$0.85+8.63%$0.92$0.802,992 shs$30.76 million11/04/2024$0.73$0.78+7.78%$0.87$0.7314,179 shs$28.32 million11/01/2024$0.80$0.73-9.24%$0.85$0.737,373 shs$26.27 million10/31/2024$0.81$0.80-1.80%$0.88$0.6372,687 shs$29.10 million10/30/2024$0.90$0.81-8.99%$0.95$0.8121,775 shs$29.63 million10/29/2024$0.86$0.90+4.08%$0.95$0.8810,413 shs$32.56 million10/28/2024$0.90$0.86-4.44%$0.94$0.868,988 shs$31.12 million10/25/2024$0.85$0.90+5.76%$0.90$0.844,190 shs$32.74 million10/24/2024$0.87$0.85-2.18%$0.90$0.844,029 shs$30.80 million10/23/2024$0.84$0.87+4.07%$0.93$0.8514,254 shs$31.65 million10/22/2024$0.83$0.84+0.48%$0.89$0.8212,476 shs$30.41 million10/21/2024$0.87$0.83-4.37%$0.89$0.818,543 shs$30.27 million Related Companies Repare Therapeutics Stock Chart Context Therapeutics Stock Chart InflaRx Stock Chart Protalix BioTherapeutics Stock Chart Seres Therapeutics Stock Chart Alto Neuroscience Stock Chart Avalo Therapeutics Stock Chart Cabaletta Bio Stock Chart Vaxart Stock Chart Rani Therapeutics Stock Chart Receive ESLA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Estrella Immunopharma and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ESLA) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Estrella Immunopharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Estrella Immunopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
